Pascal and Francis Bibliographic Databases


Search results

Your search



A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26441

  • Page / 1058

Selection :

  • and

The duration of oral anticoagulation after deep vein thrombosis: a randomized studySCHULMAN, S; LOCKNER, D; JUHLIN-DANNFELT, A et al.Acta medica Scandinavica. 1985, Vol 217, Num 5, pp 547-552, issn 0001-6101Article

Inhibition by warfarin of liver microsomal vitamin K-reductase in warfarin-resistant and susceptible ratsMACNICOLL, A. D; NADIAN, A. K; TOWNSEND, M. G et al.Biochemical pharmacology. 1984, Vol 33, Num 8, pp 1331-1336, issn 0006-2952Article

Actualités sur les héparines = New about heparinsBONEU, B.Nouvelle revue de médecine de Toulouse. Supplément. 1984, Vol 2, Num 8, pp 406-407, issn 0753-4515Article

Analysis of the mechanism of the magnesium effect on the warfarin-albumin interactionVAN DER GIESEN, W. F; WILTING, J.Biochemical pharmacology. 1984, Vol 33, Num 10, pp 1679-1681, issn 0006-2952Article

Interaction of warfarin with human serum albumin: a stoichiometric descriptionLARSEN, F. G; LARSEN, C. G; JAKOBSEN, P et al.Molecular pharmacology. 1985, Vol 27, Num 2, pp 263-270, issn 0026-895XArticle

Utilité de la surveillance biologique de l'héparinothérapie à visée curative = Usefulness of a biological supervision during curative heparinotherapyDEMICHELIS, C; COHEN, S; BRAGUER, D et al.Journal de pharmacie clinique (Paris). 1984, Vol 3, Num 3-4, pp 367-373, issn 0291-1981Article

Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165HOSAKA, Yoshitaka; MATSUMOTO, Miwa; ISHII, Hidemi et al.European journal of pharmacology. 2006, Vol 529, Num 1-3, pp 164-171, issn 0014-2999, 8 p.Article

Anticoagulantly active heparin-like molecules from mast cell-deficient miceMARCUM, J. A; MCKENNEY, J. B; GALLI, S. J et al.American journal of physiology. Heart and circulatory physiology. 1986, Vol 19, Num 5, pp H879-H888, issn 0363-6135Article

Heparin: applications and future prospectsQUICK, D; TROWBRIDGE, A. A.Chest. 1985, Vol 88, Num 5, pp 755-757, issn 0012-3692Article

The new understanding of the drug heparinJAQUES, L. B.Chest. 1985, Vol 88, Num 5, pp 751-754, issn 0012-3692Article

Contra: Antidotes for novel anticoagulants? ― Do we really need themEERENBERG, Elise S; LEVI, Marcel; BULLER, Harry R et al.Thrombosis and haemostasis. 2012, Vol 108, Num 4, pp 623-624, issn 0340-6245, 2 p.Article

Frequency of attendance at anticoagulant clinics: a prospective studyHOWARD, M. R; MILLIGAN, D. W.British medical journal (1857). 1988, Vol 296, Num 6626, issn 0007-1447Article

Effect of heparin in vivo on the in vitro assay of free thyroxineLINDSTEDT, G; LUNDBERG, P.-A; JAGENBURG, R et al.Scandinavian journal of clinical & laboratory investigation. 1983, Vol 43, Num 7, pp 643-646, issn 0036-5513Article

The influence of maintaining the correct whole blood-to-anticoagulant ratio during donation on the quality of leukoreduced whole bloodKARGER, Ralf; LUKOW, Christian; KRETSCHMER, Volker et al.Transfusion (Philadelphia, PA). 2011, Vol 51, Num 7, pp 1486-1492, issn 0041-1132, 7 p., 1Article

New anticoagulants ― how do they work ?KOZEK, S.Acta anaesthesiologica belgica. 2010, Vol 61, Num 3, issn 0001-5164, p. 125Conference Paper

Activated clotting time for control of anticoagulation during surgeryLEFEMINE, A. A; LEWIS, M.The American surgeon. 1985, Vol 51, Num 5, pp 274-278, issn 0003-1348Article

Determination of plasma heparin by polybrene neutralizationNASH, P. V; BJORNSSON, T. D.Analytical biochemistry. 1984, Vol 138, Num 2, pp 319-323, issn 0003-2697Article

Prolonged anticoagulation in rat poisoningJONES, E. C; GROWE, G. H; NAIMAN, S. C et al.JAMA, the journal of the American Medical Association. 1984, Vol 252, Num 21, pp 3005-3007, issn 0098-7484Article

Hémostase Nouveaux anticoagulants: bien les connaître pour bien les prescrire : NOUVEAUTES EN MEDECINE 2011 (DEUXIEME PARTIE) = New anticoagulants: to know them in order to prescribe them appropriatelyBOEHLEN, F; DE MOERLOOSE, P.Revue médicale suisse. 2012, Vol 8, Num 324, pp 96-99, issn 1660-9379, 4 p.Article

Sulfated N-(carboxymethyl)chitosans: novel blood anticoagulantsMUZZARELLI, R. A. A; TANFANI, F; EMANUELLI, M et al.Carbohydrate research. 1984, Vol 126, Num 2, pp 225-231, issn 0008-6215Article

Intracranial fluid blood levels in the anticoagulated patientsLIVONI, J. P; MCGAHAN, J. P.Neuroradiology (Berlin. Print). 1983, Vol 25, Num 5, pp 335-337, issn 0028-3940Article

A collaborative study designed to establish the 4th international standard for heparinTHOMAS, D. P; CURTIS, A. D; BARROWCLIFFE, T. W et al.Thrombosis and haemostasis. 1984, Vol 52, Num 2, pp 148-153, issn 0340-6245Article

Les héparines = HeparinsLa Revue du praticien (Paris). 1988, Vol 38, Num 15, pp 917-964, issn 0035-2640, 44 p.Article

Thrombomodulin, an endothelial anticoagulant protein, is absent from the human brainISHII, H; SALEM, H. H; BELL, C. E et al.Blood. 1986, Vol 67, Num 2, pp 362-365, issn 0006-4971Article

Acquired circulating anticoagulantsKUNKEL, L. A.Hematology/oncology clinics of North America. 1992, Vol 6, Num 6, pp 1341-1357, issn 0889-8588Article

  • Page / 1058